Literature DB >> 7535697

Nitric oxide and the pathogenesis of heart muscle disease.

A J de Belder1, M W Radomski, J F Martin, S Moncada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7535697     DOI： 10.1111/j.1365-2362.1995.tb01517.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  3 in total

1.  Leptin levels in Henoch-Schönlein purpura.

Authors:  Yuksel Aliyazicioglu; Ozan Ozkaya; Husamettin Yakut; Ismail Islek; Muhlise Alvur
Journal:  Clin Rheumatol       Date:  2006-07-01       Impact factor: 2.980

2.  The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.

Authors:  Y Guo; W K Jones; Y T Xuan; X L Tang; W Bao; W J Wu; H Han; V E Laubach; P Ping; Z Yang; Y Qiu; R Bolli
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.

Authors:  Qianhong Li; Yiru Guo; Yu-Ting Xuan; Charles J Lowenstein; Susan C Stevenson; Sumanth D Prabhu; Wen-Jian Wu; Yanqing Zhu; Roberto Bolli
Journal:  Circ Res       Date:  2003-04-18       Impact factor: 17.367
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.